This month’s issue highlights that Paxman has initiated a substantial internationalisation of coldcap.com, the company’s patient support website. In January, Arabic, French, German, Italian and Swedish versions went live, and more languages will follow throughout 2022. This much appreciated website is offered to promote Paxman’s commitment to making patient education and awareness materials accessible to all, no matter where in the world you are.

The newsletter also includes information on the launch of Paxman’s new Changing the Face of Cancer Podcast, where CEO Richard Paxman talks with renowned oncologists, clinical researchers and medical thought leaders on side effect management, orders for several systems to the US, the UK, France, Switzerland, the Netherlands, the Czech Republic, Greece and Brazil, and that the company’s partner in Japan is hosting a webinar on January 28 on best practises when implementing scalp cooling.

To read the newsletter and subscribe for upcoming issues, follow this link:

https://bit.ly/paxjan22en

Paxman’s investor newsletter is published monthly as a part of the company’s effort to strengthen its market communication together with the IR communication agency Honeybadger. Every published issue of the newsletter is available on Paxman’s website for investors, www.paxman.se. The company encourages feedback and requests on topics for upcoming issues of the newsletter.